Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 2
2003 2
2006 1
2007 1
2009 2
2010 4
2011 1
2012 4
2013 7
2014 6
2015 6
2016 7
2017 7
2018 3
2019 2
2020 2
2021 2
2022 5
2024 6
2025 5
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Opsoclonus.
Margolin E, Kaur K, Jeeva-Patel T. Margolin E, et al. 2025 May 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. 2025 May 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–. PMID: 33232023 Free Books & Documents.
Postvaccination immune-mediated encephalopathy and autoimmune encephalitis, including anti-N-methyl-D-aspartate receptor (anti-NMDA) encephalitis, anti-glutamic acid decarboxylase (anti-GAD) antibody-associated syndromes, and opsoclonus related to Sjogren syndrome, …
Postvaccination immune-mediated encephalopathy and autoimmune encephalitis, including anti-N-methyl-D-aspartate receptor (anti-NMDA) encepha …
[Memantine].
Molinuevo JL. Molinuevo JL. Neurologia. 2003 Jun;18(5):255-61. Neurologia. 2003. PMID: 12768511 Review. Spanish.
N-methyl-D-aspartate (NMDA) receptor antagonists have very extensive therapeutic potential in several central nervous system disorders and can be used as neuroprotective treatment in chronic neurodegenerative diseases and as symptomatic treatment in other neurologic diseas …
N-methyl-D-aspartate (NMDA) receptor antagonists have very extensive therapeutic potential in several central nervous system disorders and c …
Ultrasonic Neuromodulation via Astrocytic TRPA1.
Oh SJ, Lee JM, Kim HB, Lee J, Han S, Bae JY, Hong GS, Koh W, Kwon J, Hwang ES, Woo DH, Youn I, Cho IJ, Bae YC, Lee S, Shim JW, Park JH, Lee CJ. Oh SJ, et al. Curr Biol. 2019 Oct 21;29(20):3386-3401.e8. doi: 10.1016/j.cub.2019.08.021. Epub 2019 Oct 3. Curr Biol. 2019. PMID: 31588000 Free article.
Low-intensity, low-frequency ultrasound (LILFU) is the next-generation, non-invasive brain stimulation technology for treating various neurological and psychiatric disorders. ...These discoveries should prove to be useful for optimization of human brain stimu …
Low-intensity, low-frequency ultrasound (LILFU) is the next-generation, non-invasive brain stimulation technology for treating variou …
Kynurenines and Glutamate: Multiple Links and Therapeutic Implications.
Schwarcz R. Schwarcz R. Adv Pharmacol. 2016;76:13-37. doi: 10.1016/bs.apha.2016.01.005. Epub 2016 Mar 11. Adv Pharmacol. 2016. PMID: 27288072 Free PMC article. Review.
Glutamate is firmly established as the major excitatory neurotransmitter in the mammalian brain and is actively involved in most aspects of neurophysiology. Moreover, glutamatergic impairments are associated with a wide variety of dysfunctional states, and both hypo- and h …
Glutamate is firmly established as the major excitatory neurotransmitter in the mammalian brain and is actively involved in most aspe …
Sleep disturbance impaired memory consolidation via lateralized disruption of metabolite in the thalamus and hippocampus: A cross-sectional proton magnetic resonance spectroscopy study.
Fan X, Mao X, Yu P, Han D, Chen C, Wang H, Zhang X, Liu S, Chen W, Chen Z, Du X, Jin L, Song Y, Li H, Zhang N, Wu Y, Chang L, Wang C. Fan X, et al. J Alzheimers Dis. 2024 Dec;102(4):1057-1073. doi: 10.1177/13872877241295401. Epub 2024 Nov 25. J Alzheimers Dis. 2024. PMID: 39584303
In clinical research, 49 participants were divided into four groups: healthy controls (HC, n = 11), insomnia with normal cognition (IS, n = 14), mild cognitive impairment without insomnia (MCI, n = 10), and insomnia with mild cognitive impairment (IS-MCI, n = 14). ...Resul …
In clinical research, 49 participants were divided into four groups: healthy controls (HC, n = 11), insomnia with normal cognition (I …
Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.
Massie A, Boillée S, Hewett S, Knackstedt L, Lewerenz J. Massie A, et al. J Neurochem. 2015 Dec;135(6):1062-79. doi: 10.1111/jnc.13348. Epub 2015 Sep 29. J Neurochem. 2015. PMID: 26336934 Free PMC article. Review.
As such, system xc(-) can regulate the antioxidant capacity of cells. Moreover, in several brain regions, system xc(-) is the major source of extracellular glutamate. As such this antiporter is able to fulfill key physiological functions in the CNS, while evidence indicate …
As such, system xc(-) can regulate the antioxidant capacity of cells. Moreover, in several brain regions, system xc(-) is the major s …
Metabotropic glutamate receptor 3 as a potential therapeutic target for psychiatric and neurological disorders.
Dogra S, Putnam J, Conn PJ. Dogra S, et al. Pharmacol Biochem Behav. 2022 Nov;221:173493. doi: 10.1016/j.pbb.2022.173493. Epub 2022 Nov 17. Pharmacol Biochem Behav. 2022. PMID: 36402243 Free PMC article. Review.
As metabotropic glutamate receptor 3 (mGlu(3) receptor) regulates glutamatergic transmission in various brain areas, emerging literature suggests that targeting mGlu(3) receptors can be a novel approach to the treatment of psychiatric and neurological disorders. ... …
As metabotropic glutamate receptor 3 (mGlu(3) receptor) regulates glutamatergic transmission in various brain areas, emerging literat …
Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.
Felipo V. Felipo V. World J Gastroenterol. 2006 Dec 28;12(48):7737-43. doi: 10.3748/wjg.v12.i48.7737. World J Gastroenterol. 2006. PMID: 17203513 Free PMC article. Review.
These studies show that the function of the signal transduction pathway glutamate-nitric oxide-cGMP associated to the NMDA type of glutamate receptors is impaired in brain in vivo in HE animal models as well as in brain of patients died of HE. Activation of NMDA rec …
These studies show that the function of the signal transduction pathway glutamate-nitric oxide-cGMP associated to the NMDA type of glutamate …
Disrupting nNOS-PSD95 Interaction Improves Neurological and Cognitive Recoveries after Traumatic Brain Injury.
Qu W, Liu NK, Wu X, Wang Y, Xia Y, Sun Y, Lai Y, Li R, Shekhar A, Xu XM. Qu W, et al. Cereb Cortex. 2020 Jun 1;30(7):3859-3871. doi: 10.1093/cercor/bhaa002. Cereb Cortex. 2020. PMID: 31989159 Free PMC article.
Excessive activation of N-methyl-D-aspartate receptors (NMDARs) and the resulting neuronal nitric oxide synthase (nNOS) activation plays a crucial role in the pathogenesis of traumatic brain injury (TBI). However, directly inhibiting NMDARs or nNOS produces adverse side ef …
Excessive activation of N-methyl-D-aspartate receptors (NMDARs) and the resulting neuronal nitric oxide synthase (nNOS) activation plays a c …
A spontaneous hyperglycaemic cynomolgus monkey presents cognitive deficits, neurological dysfunction and cataract.
Huang H, Pu J, Zhou Y, Fan Y, Zhang Y, Li Y, Chen Y, Wang Y, Yu X, Dmitry B, Zhou Z, Wang J. Huang H, et al. Clin Exp Pharmacol Physiol. 2024 Jun;51(6):e13863. doi: 10.1111/1440-1681.13863. Clin Exp Pharmacol Physiol. 2024. PMID: 38650114
The results were shown that the HGM monkey had persistent body weight loss, long-term hyperglycaemia, insulin resistance, dyslipidemia, but normal concentrations of insulin, C-peptide, insulin autoantibody, islet cell antibody and glutamic acid decarboxylase antibod …
The results were shown that the HGM monkey had persistent body weight loss, long-term hyperglycaemia, insulin resistance, dyslipidemia, but …
66 results